Triple allergic contact sensitivities due to ferbinac, crotamiton and diisopropanolamine.
Oiso
Naoki
N
Department of Dermatology, Saiseikai Tondabayashi Hospital, 1-3-36 Koyodai, Tondabayashi, Osaka 584-0082, Japan. naokioiso@msic.med.osaka-cu.ac.jp
Fukai
Kazuyoshi
K
Ishii
Masamitsu
M
D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D000368:Aged; D000485:Allergens / Q000009:adverse effects; D017449:Dermatitis, Allergic Contact / Q000175:diagnosis / Q000188:drug therapy / Q000209:etiology*; D003875:Drug Eruptions / Q000175:diagnosis / Q000209:etiology*; D005500:Follow-Up Studies; D006801:Humans; D008297:Male; D010328:Patch Tests; D011412:Propanolamines / Q000009:adverse effects*; D018570:Risk Assessment; D012720:Severity of Illness Index; D014052:Toluidines / Q000009:adverse effects*
D000305:Adrenal Cortex Hormones; D000485:Allergens; D011412:Propanolamines; D014052:Toluidines; C060040:diisopropanolamine; C005553:crotamiton